510(k) K193589
K193589 is an FDA 510(k) premarket notification submitted by Allergan for the device "TrueTear Intranasal Tear Neurostimulator". The FDA issued a decision of Substantially Equivalent on Aug 31, 2020. The device falls under product code QBR (Intranasal Electrostimulation Device For Dry Eye Symptoms), a Class II device regulated under 21 CFR 886.5310. Allergan has 38 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 31, 2020
- Date Received
- Dec 23, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Intranasal Electrostimulation Device For Dry Eye Symptoms
- Device Class
- Class II
- Regulation Number
- 886.5310
- Review Panel
- OP
- Submission Type
- 510(k)
This device type is intended to temporarily increase tear production using neurostimulation to improve dry eye symptoms. For prescription use only.
Need the full FDA record for Allergan? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.